The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

ROACH: I am 5 feet, 1 inch tall, weigh 200 pounds, and have found it next to impossible to lose weight, even though I'm active. I swim, walk, or do yoga almost every day. I avoid most processed foods ...

Rapper Fat Joe recently shared how he’s been using the Type 2 diabetes medication Ozempic to maintain his 200-pound weight ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Taking Ozempic can cause nausea, diarrhea, vomiting, and potential muscle loss. Here, doctors share common and uncommon side ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

The Food and Drug Administration said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...